Nu-Med Plus, Inc. (NUMD) stock
Close on Oct 19, 2026Market cap $601.55KP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $601.55K
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$20.79K
- EPS, diluted
- $0.00
- Book value per share
- -$0.00
- Diluted shares
- 84M
Trading
- Previous close
- $0.01
- Open
- $0.01
- Day's range
- $0.01 – $0.01
- Volume
- 160,000
- Average volume (20 days)
- 57,767
Market cap history
Month-end market cap since 2014, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | NUMD | S&P 500 | Difference | NUMD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -68.7% | +0.6% | −69.3 pts | ||
| 3 months | -60.9% | +3.4% | −64.2 pts | ||
| Year to date | -58.3% | +13.3% | −71.6 pts | ||
| 1 year | -76.0% | +16.6% | −92.6 pts | ||
| 3 years | -67.3% | +86.4% | −153.7 pts | -31.1% | +23.1% |
| 5 years | -89.9% | +81.9% | −171.7 pts | -36.8% | +12.7% |
| 10 years | -98.4% | +318.9% | −417.2 pts | -33.7% | +15.4% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Nu-Med Plus filed with the SEC as exhibits to Form 8-K or 6-K
About Nu-Med Plus
Gold and Silver Ores
Nu-Med Plus, Inc. is a medical device company focused on the design, development, and commercialization of technologies utilizing nitric oxide in the medical field. The company develops proprietary formulations to generate nitric oxide gas on demand, eliminating the need for compressed gas cylinders. Its product pipeline includes hospital nitric oxide delivery devices for intensive care ventilator patients, clinical delivery systems for doctor offices and clinics, mobile rechargeable devices for inhalation therapy, disposable treatment units, and gas dilution systems for research applications. The company targets applications across hospital intensive care units, outpatient clinics, and research laboratories.
Company profile, executives and historyNu-Med Plus stock: common questions
What is Nu-Med Plus's stock price?
NUMD closed at $0.01 on Oct 19, 2026, down 8.16% on the day.
What is Nu-Med Plus's market cap?
Nu-Med Plus was worth $601.55K at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is NUMD's P/E ratio?
Nu-Med Plus lost money over the twelve months to Jun 30, 2026 (diluted EPS $0.00), so it has no meaningful P/E ratio.
Does Nu-Med Plus pay a dividend?
No. Nu-Med Plus has not paid a cash dividend over the last twelve months.
How has NUMD stock performed over the past year?
Including dividends, NUMD returned -76.0% over the past year, against +16.6% for the S&P 500.
Who are Nu-Med Plus's competitors?
Companies most similar to Nu-Med Plus by business, industry and size include XAIR, STME, QTEX, MODD, AURX.
See a number that looks wrong?